Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Intensive Care Medicine|December 8, 2010
Optimization of meropenem dosage in the critically ill population based on renal functionJared L Crandon, Robert E Ariano, Sheryl A Zelenitsky, et al.
Pharmacotherapy|April 2, 2021
Pharmacokinetics and safety of lefamulin after single intravenous dose administration in subjects with impaired renal function and those requiring hemodialysisWolfgang W Wicha, Thomas C Marbury, James A Dowell, et al.
Pharmacotherapy|April 3, 2021
Pharmacokinetics and safety of lefamulin after single intravenous dose administration in subjects with impaired-hepatic functionWolfgang W Wicha, Thomas C Marbury, James A Dowell, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2009
Population pharmacokinetics of high-dose, prolonged-infusion cefepime in adult critically ill patients with ventilator-associated pneumoniaAnthony M Nicasio, Robert E Ariano, Sheryl A Zelenitsky, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2012
Comparative in vitro and in vivo efficacies of human simulated doses of ceftazidime and ceftazidime-avibactam against Pseudomonas aeruginosaJared L Crandon, Virna J Schuck, Mary Anne Banevicius, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2024
In vitro activity of taurolidine against clinical Candida auris isolates: relevance to catheter-related bloodstream infectionsBruce E Reidenberg, Stephen G Jenkins, Jared L Crandon, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2013
Adaptation-based resistance to siderophore-conjugated antibacterial agents by Pseudomonas aeruginosaAndrew P Tomaras, Jared L Crandon, Craig J McPherson, et al.
Antimicrobial Agents and Chemotherapy|September 23, 2009
Bronchopulmonary disposition of intravenous voriconazole and anidulafungin given in combination to healthy adultsJared L Crandon, Mary Anne Banevicius, Annie F Fang, et al.
Antimicrobial Agents and Chemotherapy|October 7, 2015
Pharmacodynamic Profiling of a Siderophore-Conjugated Monocarbam in Pseudomonas aeruginosa: Assessing the Risk for Resistance and Attenuated EfficacyAryun Kim, Amy Kutschke, David E Ehmann, et al.
ACS Medicinal Chemistry Letters|July 21, 2015
Discovery and Characterization of a Water-Soluble Prodrug of a Dual Inhibitor of Bacterial DNA Gyrase and Topoisomerase IVHardwin O'Dowd, Dean E Shannon, Kishan R Chandupatla, et al.
Pageof 7